
EW
Edwards Lifesciences Corporation
Company Overview
| Mkt Cap | $44.77B | Price | $84.15 |
| Volume | 11.82M | Change | +5.56% |
| P/E Ratio | 10.7 | Open | $82.50 |
| Revenue | $5.4B | Prev Close | $79.72 |
| Net Income | $4.2B | 52W Range | $68.63 - $87.89 |
| Div Yield | N/A | Target | $95.86 |
| Overall | 64 | Value | 55 |
| Quality | 57 | Technical | 80 |
No chart data available
About Edwards Lifesciences Corporation
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally. The company offers transcatheter heart valve replacement products for minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband brands. It also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS brand name; INSPIRIS RESILIA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valve conduit for complex combined procedures; and MITRIS RESILIA valve. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Latest News
Is Coca-Cola Stock (KO) a Buy Before April 28 Earnings?
‘Time to Double Down,’ Says Investor About XRP
Stratosphere and Strategic Investors Acquire 70% Stake in Potion Alpha
Who Is Betting Big on SoFi? A Look at Top Shareholders Ahead of Q1 Results
Newmont (NEM) Earnings Review: BMO Analyst Hikes PT to $145 after Strong Q1 Results
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EW | $84.15 | +5.6% | 11.82M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Edwards Lifesciences Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW